Literature DB >> 22474323

Prostaglandin EP1 receptor down-regulates expression of cyclooxygenase-2 by facilitating its proteasomal degradation.

Ariz Haddad1, Galit Flint-Ashtamker, Waleed Minzel, Rapita Sood, Gilad Rimon, Liza Barki-Harrington.   

Abstract

The enzyme cyclooxygenase-2 (COX-2) is rapidly and transiently up-regulated by a large variety of signals and implicated in pathologies such as inflammation and tumorigenesis. Although many signals cause COX-2 up-regulation, much less is known about mechanisms that actively down-regulate its expression. Here we show that the G protein-coupled receptor prostaglandin E(1) (EP(1)) reduces the expression of COX-2 in a concentration-dependent manner through a mechanism that does not require receptor activation. The reduction in COX-2 protein is not due to decreased protein synthesis and occurs because of enhancement of substrate-independent COX-2 proteolysis. Although EP(1) does not interfere with the entry of COX-2 into the endoplasmic reticulum-associated degradation cascade, it facilitates COX-2 ubiquitination through complex formation. Blockade of proteasomal activity results in degradation of the receptor and concomitant recovery in the expression of COX-2, suggesting that EP(1) may scaffold an unknown E3 ligase that ubiquitinates COX-2. These findings propose a new role for the EP(1) receptor in resolving inflammation through down-regulation of COX-2.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22474323      PMCID: PMC3366802          DOI: 10.1074/jbc.M111.304220

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Proteasome involvement in agonist-induced down-regulation of mu and delta opioid receptors.

Authors:  K Chaturvedi; P Bandari; N Chinen; R D Howells
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

Review 2.  Prostanoid receptors: subtypes and signaling.

Authors:  R M Breyer; C K Bagdassarian; S A Myers; M D Breyer
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

3.  Newly synthesized human delta opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome.

Authors:  U E Petaja-Repo; M Hogue; A Laperriere; S Bhalla; P Walker; M Bouvier
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

4.  Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4.

Authors:  Fabien M Décaillot; Raphael Rozenfeld; Achla Gupta; Lakshmi A Devi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-03       Impact factor: 11.205

5.  Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2.

Authors:  Ping Wang; Hua Gao; Yanxiang Ni; Beibei Wang; Yalan Wu; Lili Ji; Linhua Qin; Lan Ma; Gang Pei
Journal:  J Biol Chem       Date:  2002-12-17       Impact factor: 5.157

6.  N-acetylcysteine and celecoxib lessen cadmium cytotoxicity which is associated with cyclooxygenase-2 up-regulation in mouse neuronal cells.

Authors:  Maria E Figueiredo-Pereira; Zongmin Li; Marlon Jansen; Patricia Rockwell
Journal:  J Biol Chem       Date:  2002-05-07       Impact factor: 5.157

7.  Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin.

Authors:  S K Shenoy; P H McDonald; T A Kohout; R J Lefkowitz
Journal:  Science       Date:  2001-10-04       Impact factor: 47.728

8.  Prostaglandin E(2) upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages.

Authors:  B Hinz; K Brune; A Pahl
Journal:  Biochem Biophys Res Commun       Date:  2000-06-16       Impact factor: 3.575

Review 9.  Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.

Authors:  L A Harker
Journal:  Circulation       Date:  1986-02       Impact factor: 29.690

10.  Thrombin up-regulates tissue factor pathway inhibitor-2 synthesis through a cyclooxygenase-2-dependent, epidermal growth factor receptor-independent mechanism.

Authors:  Véronique Neaud; Jennifer Gillibert Duplantier; Claire Mazzocco; Walter Kisiel; Jean Rosenbaum
Journal:  J Biol Chem       Date:  2003-11-17       Impact factor: 5.157

View more
  8 in total

1.  PGE2 EP1 receptor inhibits vasopressin-dependent water reabsorption and sodium transport in mouse collecting duct.

Authors:  Rania Nasrallah; Joseph Zimpelmann; David Eckert; Jamie Ghossein; Sean Geddes; Jean-Claude Beique; Jean-Francois Thibodeau; Chris R J Kennedy; Kevin D Burns; Richard L Hébert
Journal:  Lab Invest       Date:  2017-12-18       Impact factor: 5.662

2.  Down-regulation of cyclooxygenase-2 by the carboxyl tail of the angiotensin II type 1 receptor.

Authors:  Rapita Sood; Waleed Minzel; Gilad Rimon; Sharon Tal; Liza Barki-Harrington
Journal:  J Biol Chem       Date:  2014-09-17       Impact factor: 5.157

Review 3.  Cyclooxygenase 2: protein-protein interactions and posttranslational modifications.

Authors:  Anna Alexanian; Andrey Sorokin
Journal:  Physiol Genomics       Date:  2017-09-22       Impact factor: 3.107

4.  A cyclooxygenase-2-dependent prostaglandin E2 biosynthetic system in the Golgi apparatus.

Authors:  Chong Yuan; William L Smith
Journal:  J Biol Chem       Date:  2014-12-29       Impact factor: 5.157

5.  Upregulation of prostaglandin receptor EP1 expression involves its association with cyclooxygenase-2.

Authors:  Rapita Sood; Galit Flint-Ashtamker; Dafna Borenstein; Liza Barki-Harrington
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

Review 6.  Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration.

Authors:  Maria E Figueiredo-Pereira; Patricia Rockwell; Thomas Schmidt-Glenewinkel; Peter Serrano
Journal:  Front Mol Neurosci       Date:  2015-01-13       Impact factor: 5.639

7.  Prostaglandins and rheumatoid arthritis.

Authors:  Mohammad Javad Fattahi; Abbas Mirshafiey
Journal:  Arthritis       Date:  2012-11-07

8.  Identification of prostaglandin receptors in human ureters.

Authors:  Matthias Oll; Claudia Baumann; Turang E Behbahani; Alexander von Ruecker; Stefan C Müller; Jörg Ellinger
Journal:  BMC Urol       Date:  2012-12-10       Impact factor: 2.264

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.